Dianthus Therapeutics posts updated corporate presentation; no specific financial or operational news disclosed

Dianthus Therapeutics, Inc. /DE/

Filed under Item 8.01; presentation posted on IR section of website dated December 2024.
No new financial results, guidance, or material events are provided in the filing text.
The exhibit (Ex-99.1) is a corporate presentation slide deck, but its content is not summarized in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.